Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stentrode With Thought-controlled Digital Switch: An Early Feasibility Study of the Safety of an Endovascular Motor Neuroprosthesis in Participants With Severe Upper Limb Impairment.

NCT05041114 is registered in ClinicalTrials.gov with Synchron Medical, Inc. as lead sponsor.

NCT NCT05041114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05041114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stentrode With Thought-controlled Digital Switch: An Early Feasibility Study of the Safety of an Endovascular Motor Neuroprosthesis in Participants With Severe Upper Limb Impairment.
Lead sponsor
Synchron Medical, Inc.
Phase
Not applicable
Overall status
Withdrawn
Start date
April 21, 2022
Completion date
November 30, 2022
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis, muscular dystrophies, neurologic disorder, paralysis, paralysis; stroke, spinal cord injury, spinal muscular atrophy, stroke, brainstem, stroke, lacunar, upper limb injury